Products | January 28, 2009

ProVation MD

ProVation MD

Related Content

Rapid Growth of Radiopharmaceutical Therapy Highlights Need for Expertise
News | Radiopharmaceuticals and Tracers
Rapid Growth of Radiopharmaceutical Therapy Highlights Need for Expertise

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Focused Ultrasound Therapy
Researchers Develop New Technique that Uses Ultrasound to Activate Drugs Targeting Pancreatic Cancer

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
Studycast Purchases UltraLinQ
News | PACS
Studycast Purchases UltraLinQ

Aug. 26, 2025 — Core Sound Imaging, the company behind the widely established Studycast medical imaging workflow ...

Time August 26, 2025
arrow
GE HealthCare Receives FDA Clearance for Aurora and Clarify DL,
News | Nuclear Imaging
GE HealthCare Receives FDA Clearance for Aurora and Clarify DL

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
NANO-X ARC
News | Computed Tomography (CT)
Nanox Gets FDA Clearance for New Imaging System

April 17, 2025 — Nano-X Imaging LTD has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Time April 18, 2025
arrow
Konic Minolta Exa PACS
News | PACS
Konica Minolta Launches Next-Gen Exa Platform with Embedded Advanced Visualization Functionality

April 3, 2025 – Konica Minolta Healthcare Americas, Inc. has launched the next-generation of the Exa Platform with the ...

Time April 15, 2025
arrow
News | Enterprise Imaging
Konica Minolta Healthcare Debuts Exa Enterprise

Nov. 13, 2024 – Konica Minolta Healthcare Americas, Inc.has launched Exa Enterprise, an enterprise imaging solution with ...

Time November 14, 2024
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Prostate Cancer
Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Multi-year supply agreement for radium-226 processing and purification
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now